Treatment Innovations

Navigating the Future of Pharma: AAPS PharmSci 360 to Address the Crisis of Credibility and the Post-Animal Frontier

• Treatment Innovations

Navigating the Future of Pharma: AAPS PharmSci 360 to Address the Crisis of Credibility and the Post-Animal Frontier

Asep Darmawan October 2, 2026

As the pharmaceutical industry stands at a critical juncture defined by rapid technological acceleration and a growing...

Read More Read more about Navigating the Future of Pharma: AAPS PharmSci 360 to Address the Crisis of Credibility and the Post-Animal Frontier

A New Horizon for Pediatric Cardiology: FDA Approves Edwards Lifesciences’ Expandable Autus Heart Valve

• Treatment Innovations

A New Horizon for Pediatric Cardiology: FDA Approves Edwards Lifesciences’ Expandable Autus Heart Valve

Nana October 2, 2026

In a landmark development for pediatric cardiac care, the U.S. Food and Drug Administration (FDA) has granted...

Read More Read more about A New Horizon for Pediatric Cardiology: FDA Approves Edwards Lifesciences’ Expandable Autus Heart Valve

Novo Nordisk Strikes Strategic Deal for Next-Gen Obesity Candidate to Challenge Lilly’s Dominance

• Treatment Innovations

Novo Nordisk Strikes Strategic Deal for Next-Gen Obesity Candidate to Challenge Lilly’s Dominance

Rifan Muazin October 2, 2026

By Jonathan Gardner Published September 29, 2026 In a high-stakes move to regain its competitive footing in...

Read More Read more about Novo Nordisk Strikes Strategic Deal for Next-Gen Obesity Candidate to Challenge Lilly’s Dominance

DEA Escalates Regulatory Crackdown on Synthetic Kratom Derivatives

• Treatment Innovations

DEA Escalates Regulatory Crackdown on Synthetic Kratom Derivatives

Asep Darmawan October 2, 2026

In a significant move aimed at curbing the proliferation of potent, lab-synthesized psychoactive substances, the U.S. Drug...

Read More Read more about DEA Escalates Regulatory Crackdown on Synthetic Kratom Derivatives

The Industrialization Imperative: Why Manufacturing Capacity is the New Frontier in Drug Delivery

• Treatment Innovations

The Industrialization Imperative: Why Manufacturing Capacity is the New Frontier in Drug Delivery

Lina Hope October 2, 2026

The pharmaceutical landscape is undergoing a profound transformation. The meteoric rise of GLP-1 receptor agonists—initially hailed for...

Read More Read more about The Industrialization Imperative: Why Manufacturing Capacity is the New Frontier in Drug Delivery

Industry Shifts and Strategic Wins: A Biopharma Market Roundup (September 2026)

• Treatment Innovations

Industry Shifts and Strategic Wins: A Biopharma Market Roundup (September 2026)

Muslim October 2, 2026

The pharmaceutical landscape is currently undergoing a period of intense structural and clinical transformation. As of September...

Read More Read more about Industry Shifts and Strategic Wins: A Biopharma Market Roundup (September 2026)

Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture

• Treatment Innovations

Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture

Nana Muazin October 2, 2026

For decades, the pharmaceutical industry has operated under a veil of insularity when it comes to the...

Read More Read more about Bridging the Transparency Gap: How Rx Almanac is Disrupting Pharma’s "Word-of-Mouth" Vendor Culture

The Evolution of Metabolic Monitoring: Beyond Glucose and Into the Era of Multimodal Sensing

• Treatment Innovations

The Evolution of Metabolic Monitoring: Beyond Glucose and Into the Era of Multimodal Sensing

Suro Senen October 2, 2026

The landscape of metabolic healthcare is undergoing a tectonic shift. For decades, the management of conditions such...

Read More Read more about The Evolution of Metabolic Monitoring: Beyond Glucose and Into the Era of Multimodal Sensing

The End of the Phased Era: HHS Launches “Surpass” to Revolutionize Clinical Trials

• Treatment Innovations

The End of the Phased Era: HHS Launches “Surpass” to Revolutionize Clinical Trials

Asro October 2, 2026

The U.S. Department of Health and Human Services (HHS) has officially signaled the beginning of a radical...

Read More Read more about The End of the Phased Era: HHS Launches “Surpass” to Revolutionize Clinical Trials

The Next Frontier: Innovation and Competition at the 2026 EASD Annual Meeting

• Treatment Innovations

The Next Frontier: Innovation and Competition at the 2026 EASD Annual Meeting

Asro October 1, 2026

The global landscape of metabolic medicine is currently defined by a high-stakes race for dominance in the...

Read More Read more about The Next Frontier: Innovation and Competition at the 2026 EASD Annual Meeting